Buchang Pharmaceutical announced that on July 28, 2026, the board of directors of the company deliberated and approved the proposed foreign investment to establish a holding subsidiary Shandong Buchang Shengshi Pharmaceutical Co., Ltd., with a registered capital of 50 million yuan, and the company invested 33.5 million yuan to hold 67% of the shares. On August 5, 2026, the company and Jinan Fuju Changyuan Enterprise Management Center officially signed the “Cooperation Agreement on Shandong Buchang Shengshi Pharmaceutical Co., Ltd.”

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.